Sale!

SNCA Gene Dementia Lewy Body Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The SNCA Gene Dementia Lewy Body Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the SNCA gene, which are associated with an increased risk of developing Lewy body dementia (LBD). Lewy body dementia is a progressive brain disorder characterized by the abnormal accumulation of alpha-synuclein protein in the brain, leading to cognitive decline, movement disorders, and psychiatric symptoms. By analyzing the SNCA gene, this test helps in confirming the diagnosis, understanding the risk, and aiding in the management of the condition for patients and their families. The test is priced at 4400 AED, reflecting the comprehensive analysis and the specialized technology utilized in identifying the genetic variations linked to this form of dementia. Conducted at DNA Labs UAE, a facility known for its advanced genetic testing capabilities, the test represents a crucial step forward in the personalized treatment and understanding of Lewy body dementia.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SNCA Gene Dementia Lewy Body Genetic Test

Components: SNCA Gene Dementia Lewy Body Genetic Test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for SNCA Gene Dementia, Lewy body NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SNCA Gene Dementia, Lewy body.

Test Details: The SNCA gene is associated with the development of Lewy body dementia, a type of dementia that is characterized by the accumulation of abnormal protein deposits in the brain. NGS (next-generation sequencing) genetic testing is a method of DNA analysis that can be used to identify mutations or variations in the SNCA gene that may increase the risk of developing Lewy body dementia. NGS genetic testing involves the sequencing of DNA fragments using high-throughput technologies, which enables the analysis of large amounts of genetic data in a short period of time. This type of testing can be used to identify mutations or variations in the SNCA gene that may increase the risk of developing Lewy body dementia. NGS genetic testing can also be used to identify other genetic factors that may contribute to the development of dementia, such as mutations in the APOE gene, which is associated with an increased risk of developing Alzheimer’s disease. Genetic testing can help individuals and their families understand their risk of developing dementia, and may also inform treatment and management decisions. However, it is important to note that genetic testing cannot predict the onset or severity of dementia with certainty, as many other factors also contribute to the development of the disease.

Test Name SNCA Gene Dementia Lewy body Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SNCA Gene Dementia, Lewy body NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with SNCA Gene Dementia, Lewy body
Test Details

The SNCA gene is associated with the development of Lewy body dementia, a type of dementia that is characterized by the accumulation of abnormal protein deposits in the brain. NGS (next-generation sequencing) genetic testing is a method of DNA analysis that can be used to identify mutations or variations in the SNCA gene that may increase the risk of developing Lewy body dementia.

NGS genetic testing involves the sequencing of DNA fragments using high-throughput technologies, which enables the analysis of large amounts of genetic data in a short period of time. This type of testing can be used to identify mutations or variations in the SNCA gene that may increase the risk of developing Lewy body dementia.

NGS genetic testing can also be used to identify other genetic factors that may contribute to the development of dementia, such as mutations in the APOE gene, which is associated with an increased risk of developing Alzheimer’s disease. Genetic testing can help individuals and their families understand their risk of developing dementia, and may also inform treatment and management decisions. However, it is important to note that genetic testing cannot predict the onset or severity of dementia with certainty, as many other factors also contribute to the development of the disease.